Metal-organic frameworks as promising solid-phase sorbents for the isolation of third-generation synthetic cannabinoids in biological samples
In this work, metal-organic frameworks (MOFs) were used for the first time as solid-phase extraction (SPE) sorbents for the isolation of synthetic cannabinoids (SCs) from oral fluids and subsequently quantified by LC-fluorescence detection (FLD). In this context, different MOF families were synthesi...
Saved in:
Published in | Analytica chimica acta Vol. 1246; p. 340887 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
15.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this work, metal-organic frameworks (MOFs) were used for the first time as solid-phase extraction (SPE) sorbents for the isolation of synthetic cannabinoids (SCs) from oral fluids and subsequently quantified by LC-fluorescence detection (FLD). In this context, different MOF families were synthesized and tested under SPE mode. UiO-66 was the family selected, being the amino functionalized (NH2-UiO-66) the best candidate in terms of extraction performance. After the method optimization, several analytical parameters of interest were obtained, reaching limits of detection (LODs) as low as 0.6–0.8 μg L−1 and precision values (expressed as RSD) lower than 10.6%. The developed method was successfully applied to the determination of 8 SCs in different oral fluids at three spiked levels with recoveries between 67 and 114%. This method claims to be a real alternative for screening purposes, being a cost-effective procedure due to the price of the sorbent (<0.5 €/cartridge) and its recyclability (up to 12 uses), among others good features.
[Display omitted]
•MOFs are used for the first time as SPE sorbents for isolation of synthetic cannabinoids.•NH2-UiO-66 has shown the best results in terms of extraction performance.•SPE-LC-FLD provided good LODs and suitable recoveries.•The SPE cartridges showed satisfactory reusability and low-cost (0.5 €/unit).•The optimized protocol was successfully applied to human oral fluids. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0003-2670 1873-4324 |
DOI: | 10.1016/j.aca.2023.340887 |